InMed Pharmaceuticals (INM) Non-Current Deferred Tax Liability (2022 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Non-Current Deferred Tax Liability of $20000.0 for Q2 2025, down 83.32% quarter-over-quarter from $119889.0 in Q2 2023.
InMed Pharmaceuticals (INM) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $20000.0 for Q2 2025.
- In Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $20000.0; the TTM figure through Jun 2025 stood at $20000.0 (changed N/A YoY), while the FY2025 annual figure was $20000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q2 2025 stood at $20000.0, down from $119889.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $119889.0 in Q2 2023, with the low at $16546.0 in Q2 2022.
- The 3-year median for Non-Current Deferred Tax Liability is $20000.0 (2025), against an average of $52145.0.
- Peak annual rise in Non-Current Deferred Tax Liability reached 624.58% in 2023, while the deepest fall reached 624.58% in 2023.
- InMed Pharmaceuticals' Non-Current Deferred Tax Liability stood at $16546.0 in 2022, then surged by 624.58% to $119889.0 in 2023, then sank by 83.32% to $20000.0 in 2025.
- Business Quant data shows INM's Non-Current Deferred Tax Liability at $20000.0 in Q2 2025, $119889.0 in Q2 2023, and $16546.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2023 | 119,889.00 |
| Jun 30, 2023 | 119,889.00 |
| Jun 30, 2022 | 16,546.00 |
| Jun 30, 2022 | 16,546.00 |